Opinion | March 24, 2022
Clinical Trials in the New Normal
The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay
The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay
Biolexis will also leverage the capabilities of Strides Group for launching this vaccine across regions where the group has a deep market presence and established relationships
The DCGI has already approved Covovax for restricted use in emergency situations in adults on December 28th 2021
Paxlovid consists of nirmatrelvir, which inhibits a SARS-CoV-2 protein to stop the virus from replicating, and ritonavir, which slows down nirmatrelvir’s breakdown to help it remain in the body for a longer period at higher concentrations
The recommendation has been sent to the DCGI for approval
This is the ninth Covid-19 vaccine approved in India
The recommendations have been sent to the Drugs Controller General of India (DCGI) for the final approval
Intranasal vaccines are easier to administer in mass immunisation campaigns and help reduce or stop transmission
The vaccines are currently only authorised for emergency use in the country
However, these won’t be available at the nearest chemist store soon
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
